Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Ritlecitinib can help about 14,000 people with severe hair loss.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

JAK inhibitors are effective for long-term management of alopecia areata.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Strain H61 may reduce some ageing symptoms like bone loss and hair loss.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Certain medications, hypertension, and short eye length increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

The new sulfur paste effectively treats rabbit scabies, promoting healing and hair growth.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.